ReWalk Personal Device Postmarket Study

NCT02944669 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-02-02

No results posted yet for this study

Summary

This study seeks to further evaluate the Multi-Tiered Training Program and to further explore the overall safety profile of the ReWalk Personal Device outside of the institutional setting under conditions of routine medical practice.

Conditions

  • Injuries, Spinal Cord

Interventions

DEVICE

ReWalk Personal Device

Sponsors & Collaborators

  • ReWalk Robotics, Inc.

    lead INDUSTRY

Principal Investigators

  • Mathew Smuck, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-09-30
Completion
2019-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02944669 on ClinicalTrials.gov